Skip to main content
Download PDF

Decreased visual acuity is related to thinner cortex in cognitively normal adults: cross-sectional, single-center cohort study

Alzheimer's Research & Therapy volume 14, Article number: 99 (2022) Cite this article

Abstract

Background

Decreased visual acuity (VA) is reported to be a risk factor for dementia. However, the association between VA and cortical thickness has not been established. We investigated the association between VA and cortical thickness in cognitively normal adults.

Method

We conducted a cross-sectional, single-center cohort study with cognitively normal adults (aged ≥ 45) who received medical screening examinations at the Health Promotion Center at Samsung Medical Center. Subjects were categorized as bad (VA ≤ 20/40), fair (20/40 < VA ≤ 20/25), and good (VA > 20/25) VA group by using corrected VA in the Snellen system. Using 3D volumetric brain MRI, cortical thickness was calculated using the Euclidean distance between the linked vertices of the inner and outer surfaces. We analyzed the association between VA and cortical thickness after controlling for age, sex, hypertension, diabetes, dyslipidemia, intracranial volume, and education level.

Results

A total of 2756 subjects were analyzed in this study. Compared to the good VA group, the bad VA group showed overall thinner cortex (p = 0.015), especially in the parietal (p = 0.018) and occipital (p = 0.011) lobes. Topographical color maps of vertex-wise analysis also showed that the bad VA group showed a thinner cortex in the parieto-temporo-occipital area. These results were more robust in younger adults (aged 45 to 65) as decreased VA was associated with thinner cortex in more widespread regions in the parieto-temporo-occipital area.

Conclusion

Our results suggest that a thinner cortex in the visual processing area of the brain is related to decreased visual stimuli.

Introduction

Visual disturbance is one of the most common complaints in aging. According to a global survey, an estimated 285 million people have visual problems, and two-thirds of them are aged 50 or older [1]. Several studies have suggested that visual acuity (VA) is associated with cognitive impairment. Previous studies showed that decreased VA is a risk factor for dementia [2,3,4]. Another study in the USA also demonstrated that VA was related to dementia severity [5].

Ample evidence supports the idea that decreased sensory stimuli lead to the degeneration of relevant areas in the brain. A previous study showed that hearing loss [6,7,8,9] or central vision loss due to macular degeneration [10,11,12] could cause neurodegeneration in the brain. On the other hand, reduced visual input in early life may lead to poor development in the visual processing area of the brain which may result in a thinner cortex [13]. Reversely, an inherently thinner visual cortex or dysmaturation of the visual cortex in the developmental phase may lead to decreased VA [14, 15]. However, the association between VA and cortical thickness among individuals without known ocular disease has not been established yet. Currently, the degree of cortical thickness can be measured on brain magnetic resonance imaging (MRI) [16,17,18]. As cortical atrophy precedes dementia symptoms and individuals with a thinner cortex are at higher risk for dementia [18,19,20,21], cortical thickness is an important biomarker and is used as a proxy for neurodegeneration.

Therefore, we assessed the association between VA and cortical thickness in a large cohort of cognitively normal adults (aged ≥ 45). We hypothesized that reduced VA is associated with a thinner cortex, especially in the primary visual cortex as well as in the areas related to visual processing and visual memory. We also expected that the relationship between decreased VA and cortical thickness would be more prominent in younger adults (aged 45–60), because the effect of decreased VA on thinner cortex may be masked by physiological neurodegeneration related to aging in older adults (aged > 65) [22].

Methods

Study design and participants

We retrospectively collected data on 2975 subjects aged 45 years or older who underwent a medical screening examination at the Health Promotion Center of Samsung Medical Center (Seoul, Korea) between September 2008 and December 2014. All of them underwent brain MRI including three-dimensional volume images and visual acuity assessment. We excluded the following participants: (1) subjects with significant cognitive impairment defined by an MMSE score below the 16th percentile of age- and education-matched norms (n = 169); (2) subjects with incomplete information on hypertension, diabetes, or dyslipidemia (n = 1); and (3) subjects whose cortical thickness measurement failed due to head motion artifact (n = 49). We finally included data from 2756 subjects for analysis in this study.

Standard protocol approvals, registrations, and patient consents

This study was approved by the Institutional Review Board at Samsung Medical Center. All methods were conducted in accordance with the approved guidelines. The need for informed consent was waived by the Institutional Review Board at Samsung Medical Center, as we collected retrospective and de-identified data.

Health screening examination

Health screening examination was conducted by trained health professionals according to the standard protocols at Samsung Medical Center. This included physical examination, laboratory analysis, brain MRI, and VA measurement. A standardized questionnaire was used to collect information related to demographic characteristics including hypertension, diabetes, dyslipidemia, and total duration of formal education, as previously described [23]. Hypertension was defined as systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure > 90 mmHg, a self-reported history of hypertension, or current use of antihypertensive medication. Diabetes was defined as a fasting serum glucose level greater than 126 mg/dL, self-reported diabetes history, or use of diabetes medications. Dyslipidemia was defined as a fasting total cholesterol level > 200 mg/dL, low-density lipoprotein level > 100 mg/dL, high-density lipoprotein level < 50 mg/dL, triglyceride level > 200 mg/dL, self-reported history of dyslipidemia, or current use of lipid-lowering medication.

Acquisition of brain MRI data

All participants underwent a 3D volumetric brain MRI. Previous studies have described the details of MRI protocols and the process of cortical thickness measurements [24]. In brief, an Achieva 3.0T MRI scanner (Philips, Best, The Netherlands) was applied to obtain 3D T1 turbo field echo MRI data with the following imaging parameters: sagittal slice thickness of 1.0 mm with 50% overlap, no gap, repetition time of 9.9 ms, echo time of 4.6 ms, flip angle of 8°, and matrix size of 240 × 240 pixels reconstructed to 480 × 480 over a field view of 240 mm. Radiologists initially inspected all MR images for evidence of brain tumors, lobar infarctions (except lacunar infarctions), and hemorrhages (observed as low intensity on T2-weighted images).

Cortical thickness measurement

T1-weighted MRIs were automatically analyzed with the standard Montreal Neurologic Institute image processing software (CIVET 2.1.0, http://www.bic.mni.mcgill.ca/ServicesSoftware/CIVET). The technique used in this study was previously described [25]. In summary, native MR images were registered into a standardized stereotaxic space using an affine transformation [26]. Using the artificial neural net classifier, the registered and corrected volumes were classified as white matter (WM), gray matter (GM), cerebrospinal fluid (CSF), and background [27]. Using the Laplacian-based automated segmentation with proximities algorithm, we extracted the surfaces of the inner and outer cortices by deforming the spherical mesh onto the gray-white boundaries of each hemisphere. Cortical thickness was calculated using the Euclidean distance between the linked vertices of the inner and outer surfaces, after applying an inverse transformation matrix to the surface of the cortex and reconstructing it in the native space [28]. We used classified tissue information and a skull mask acquired from the T1-weighted image and computed intracranial volume (ICV) to control for brain size [29]. ICV was defined as the sum of the volume of the GM, WM, and CSF, considering the voxel dimension. GM, WM, CSF, and the background within the mask were transformed back into the individual native space. The thicknesses were registered spatially on an unbiased iterative group template by matching the sulcal folding pattern using surface-based registration involving sphere-to-sphere warping to compare the thickness of the corresponding regions among individuals [30]. Global and regional analyses involving the frontal, temporal, parietal, and occipital lobes were performed with the SUMA program (http://afni.nimh.nih.gov) [7, 31].

Visual acuity (VA) assessment

VA was measured using the Snellen system. For individuals who wear spectacles, spectacle-corrected VA was recorded. The study subjects were classified into 3 groups based on VA in the better-seeing eye: bad (VA ≤ 20/40), fair (20/40 < VA ≤ 20/25), and good (VA > 20/25) VA. The World Health Organization uses a threshold of 20/60 for visual impairment, while 20/40 is used as the standard of visual impairment for research purposes [32,33,34]. VA ≤ 20/25 (loss of 1 line) indicates mild poor vision, which means the individual may have mild difficulty in daily life without spectacles [35, 36].

Statistical analysis

We compared demographic factors across the three groups (bad, fair, and good VA) using chi-square testing or analysis of variance.

To evaluate the association between VA and the cortical thickness of each lobe, we performed a multivariable linear regression analysis. VA group was analyzed as an ordinary variable, and the good VA was used as the reference standard. In addition, multivariable linear regression analysis was conducted using VA as a continuous variable. A subgroup analysis was performed after stratifying subjects into younger adults (aged 45 to 65) and older adults (aged > 65). All analyses were performed with adjustment for age, sex, hypertension, diabetes, dyslipidemia, education, and ICV. We selected these factors as the covariates for the multivariable linear regression based on the clinical relevance.

Analyses were performed using STATA version 15 (StataCorp. 2017. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC). Reported p-values were calculated as two-sided, and the significance level was set at 0.05.

The MATLAB-based toolbox 2014b (https://kr.mathworks.com/products/matlab.html) was used to evaluate the topography of cortical thickness related to VA. A detailed method was previously reported [37]. In brief, after diffusion smoothing to blur each cortical thickness map (leading to increased signal-to-noise ratio and statistical power), linear regression was performed vertex-by-vertex after controlling for age, sex, hypertension, diabetes, dyslipidemia, education, and ICV. Then, we analyzed the localized differences and the statistical map of cortical thickness on the surface model. The thresholds of the statistical maps were set using a false discovery rate (FDR) with a q-value of 0.05 after pooling the p-values from regression analysis.

Results

Demographics of subjects

Among the 2756 subjects, 159 subjects were classified into the bad VA group, 1256 subjects were classified into the fair VA group, and 1341 subjects were classified into the good VA group. Compared to subjects in the bad VA or fair VA groups, subjects in the good VA group were younger, more likely to be male, and had higher education levels and larger ICVs (Table 1). The distribution of VA according to age was plotted in Additional file 1: Fig. S1.

Table 1 Baseline characteristics of participants in each visual acuity (VA) groupa (total n = 2756)
Full size table

Association between VA and cortical thickness

Compared to the good VA group, subjects in the bad VA group showed reduced cortical thickness with statistical significance (ß = − 0.46, 95% confidence interval [CI] − 0.84 to − 0.09) especially in the parietal (ß = − 0.57, 95% CI − 1.05 to − 0.10) and occipital (ß = − 0.54, 95% CI − 0.96 to − 0.12) lobes in the multivariable linear regression analysis after adjusting for age, sex, hypertension, diabetes, hyperlipidemia, education, and ICV. p for trend also showed a statistically significant correlation between VA and global cortical thicknesses, as well as parietal and occipital lobe thickness (p = 0.036, 0.023, and 0.025, respectively). However, there was no statistical difference in cortical thickness between the good and fair VA groups (Table 2). The results of the subgroup analysis of corrected VA and uncorrected VA are presented in Additional file 2: Table S1.

Table 2 Analysis of the relationship between cortical thickness (x 10-1mm) and visual acuity (VA) groupsa
Full size table

The statistical topographic map also showed that VA was associated with cortical thickness in the colored areas in Fig. 1. Compared to the good VA group, subjects in the bad VA group had significantly thinner cortices, mainly in the parieto-temporo-occipital areas (bilateral superior parietal lobule, bilateral cuneus, and left lateral temporal areas) and in a focal region in the bilateral medial temporal areas (FDR corrected, q < 0.05) (Fig. 1A). However, the uncolored areas showed no significant difference between the good VA group and bad VA group (Fig. 1A).

Fig. 1
figure 1

Statistical topography of the relationship between cortical thickness and visual acuity (VA). Compared to the good VA group, the bad VA group showed a thinner cortex in the bilateral temporo-parieto-occipital lobes (A). In the analysis of the subjects who were equal or under 65 years old, a similar result was found with a larger extent and greater significance (B). False discovery rate corrected (q < 0.05). This result was adjusted for age, sex, hypertension, diabetes mellitus, hyperlipidemia, education, and intracranial volume. The MATLAB-based toolbox 2014b (https://kr.mathworks.com/products/matlab.html) was used for the drawing and the configuration of this figure

Full size image

Association between VA and cortical thickness in younger and older adults

We also analyzed the association between VA and cortical thickness after stratifying the subjects into younger (45 ≤ age ≤ 65) and older (age > 65) adults. In younger adults, the bad VA group showed a thinner cortex in the global area (ß = − 0.71, 95% CI − 1.24 to − 0.17), as well as the parietal (ß = − 0.83, 95% CI − 1.54 to − 0.13) and the occipital (ß = − 0.99, 95% CI − 1.60 to − 0.39) lobes compared to the good VA group. p for trend showed a significant relationship between cortical thickness and VA in the same area (p = 0.035, .030, and 0.005, respectively). However, in older adults, the cortical thickness of the bad VA group and fair VA group did not differ significantly from that of the good VA group (Table 2).

On the statistical map of younger adults, the bad VA group showed a thinner cortex compared to the good VA group mainly in the parieto-temporo-occipital areas, including the bilateral lateral parietal area; left precuneus, bilateral cuneus, and left lateral temporal areas; and also a focal region in the bilateral medial temporal areas (FDR corrected, q < 0.05) (Fig. 1B). However, the uncolored areas showed no significant difference between the good VA group and bad VA group in younger adults (Fig. 1B). In older adults, however, the statistical map of cortical thickness in the bad VA group and fair VA group did not differ from that of the good VA group.

Discussion

We evaluated the association between VA and cortical thickness in a large cohort of cognitively normal adults. We found that decreased VA was related to a thinner cortex mostly in the posterior regions—specifically, the parieto-temporo-occipital areas. This relationship was more robust in younger adults but was not seen in older adults. Our results imply that structural alterations in the visual processing area of the brain are related to decreased VA in cognitively normal healthy adults.

The major finding in this study was that decreased VA was associated with thinner cortex in cognitively normal adults. Although the criteria for the bad VA group in this study did not reach the visual impairment standard defined by the WHO (visual acuity ≤ 20/60), decreased VA was significantly correlated with a thinner cortex. The topography showed that this correlation was most significant in the posterior regions, specifically in the parieto-temporo-occipital area. This area is known to be responsible for processing visual information. Visual information primarily reaches the occipital lobe and then follows two streams to process this information: the dorsal stream (known as the “where pathway”) and the ventral stream (known as the “what pathway”). The “what pathway,” which spreads from the primary visual cortex to the temporal lobe, performs serial processing of perception and recognition of shape, size, objects, faces, and text [38]. On the other hand, the “where pathway,” which spreads from the primary visual cortex to the parietal lobe, processes spatial layout such as location, distance, relative position, position in egocentric space, and motion [38]. Our results suggest that the degree of visual stimuli might affect the cortical thickness in corresponding areas. We also observed that the bad VA group had a thinner cortex in the bilateral medial temporal areas compared to the good VA group. We expected the right medial temporal lobe, which is responsible for visual memory, to be more associated with decreased VA as previously suggested [39]. However, our results showed that both medial temporal lobes were associated with decreased VA. Such results suggested that brain structural alteration related to decreased VA is not limited to visual processing areas, but extends to regions related to visual and verbal memory. A previous Japanese study also showed a possible link between VA and cognitive impairment, even in cognitive domains unrelated to visuospatial function or visual memory [40].

A thinner cortex related to decreased VA was more robust in younger adults in this study. Because aging is the major factor that affects brain cortical atrophy [41], we stratified by age to minimize the effect of aging on cortical atrophy. Consequently, the relationship between VA and cortical thickness was more significant in younger adults. In older adults, there was no significant association. It is possible that reduced VA itself may not be a significant factor of cortical atrophy in older adults. It is also possible that, in older adults, other factors might have comprehensively affected cortical atrophy and may have masked the effect of decreased VA although we adjusted for possible confounders [42,43,44,45,46,47,48,49]. Another possible explanation would be neuroplasticity. That is, better VA might induce a thicker cortex especially in younger adults who are less affected by aging.

This study is the first report that included a topographical analysis of the relationship between a thinner cortex and decreased VA in cognitively normal adults. Similar studies have been conducted on patients with visual problems with known ocular diseases such as glaucoma, retinal disease, or macular disease [10, 11, 50,51,52,53,54,55,56]. These studies suggested that decreased VA from ocular diseases also could cause structural alteration in the brain, and this was pathologically confirmed in a glaucoma patient [57]. Subjects with acquired blindness were reported to have a thinner primary visual cortex [10, 11, 50,51,52,53,54,55, 58]. Our study showed that cortical atrophy patterns related to decreased VA were similar to those from studies on acquired blindness. These studies imply that decreased visual stimuli from various conditions can be related to structural changes in the brain. Considering that most of the participants in this study had no specific ocular diseases such as glaucoma or macular disease, our study inferred that a thinner cortex was related to decreased VA per se.

The pathophysiologic mechanism of the relationship between a thinner cortex and decreased VA remains unclear. One possible mechanism is desensitization. Decreased VA, which decreases visual stimuli to the brain, can cause anterograde trans-synaptic degeneration. This has been reported in visual cortices of patients with retinal disease/damage [59]. Retrograde trans-synaptic degeneration has also been observed: when the brain cortex was damaged, the number of retinal ganglion cells was reduced in regions that projected nerve fibers to the damaged cortex [51,52,53, 60, 61]. Furthermore, decreased visual stimuli also can reduce functional connectivity between the visual cortex and somatosensory area and between the visual cortex and temporal cortex, which was seen in a study of subjects with recently acquired blindness [62].

Due to the retrospective and cross-sectional nature of the study, our data does not provide a causal relationship between decreased VA and thinner cortex. Decreased VA might have affected neurodegeneration in the brain, or decreased VA might have affected poor development in the visual processing area of the brain, or reversely, an inherently thinner visual cortex or dysmaturation of the visual cortex in the developmental phase might have caused decreased VA.

Limitations

Our study has several limitations. Firstly, due to the retrospective and cross-sectional nature of our study, we could not elucidate whether the association between visual impairment and thinner cortex had a causal relationship. The lack of serum or CSF biomarkers of neurodegeneration limits the interpretation of our results as to whether a thinner cortex was due to neurodegenerative change. A further longitudinal prospective study is needed to see whether decreased VA at baseline causes a thinner cortex over time or whether longitudinal VA change is related to a thinner cortex. Secondly, we could not completely exclude individuals who had ocular diseases such as glaucoma or macular degeneration. Although we acknowledge the association between neurodegeneration and ocular diseases, the prevalence of these diseases is relatively small in the general population [63, 64]. Thus, we suspect that the significant result of a thinner cortex in this study was mostly derived from the effect of low VA itself. Third, the number of the participants in bad VA group was much smaller than the fair or good VA group. This imbalance might have led to artifactual differences related to unknown confounders. Lastly, a multi-center study in various regions or ethnicity is required to see consistent results for generalization.

Conclusion

Our results suggest that a thinner cortex in the visual processing area of the brain is related to decreased visual stimuli in cognitively normal adults.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding authors (DHL, HJK) on reasonable request.

Abbreviations

VA:

Visual acuity

WM:

White matter

GM:

Gray matter

CSF:

Cerebrospinal fluid

ICV:

Intracranial volume

logMAR:

Logarithm of the minimum angle of resolution

MMSE:

Mini-Mental State Examination

References

  1. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96(5):614–8.

    Article  PubMed  Google Scholar 

  2. Marquie M, Castilla-Marti M, Valero S, Martinez J, Sanchez D, Hernandez I, et al. Visual impairment in aging and cognitive decline: experience in a memory clinic. Sci Rep. 2019;9(1):8698.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Lee GI, Chi SA, Kim K, Seo SW, Kim HJ, Chung TY, et al. Visual impairment increases the risk of dementia, especially in young males in a 12-year longitudinal follow-up study of a national cohort. Sci Rep. 2021;11(1):11393.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Paik JS, Ha M, Jung YH, Kim GH, Han KD, Kim HS, et al. Low vision and the risk of dementia: a nationwide population-based cohort study. Sci Rep. 2020;10(1):9109.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Elyashiv SM, Shabtai EL, Belkin M. Correlation between visual acuity and cognitive functions. Br J Ophthalmol. 2014;98(1):129–32.

    Article  PubMed  Google Scholar 

  6. Ha J, Cho YS, Kim SJ, Cho SH, Kim JP, Jung YH, et al. Hearing loss is associated with cortical thinning in cognitively normal older adults. Eur J Neurol. 2020;27(6):1003–9.

    Article  CAS  PubMed  Google Scholar 

  7. Belkhiria C, Vergara RC, San Martin S, Leiva A, Marcenaro B, Martinez M, et al. Cingulate cortex atrophy is associated with hearing loss in presbycusis with cochlear amplifier dysfunction. Front Aging Neurosci. 2019;11:97.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Roberts L. The cerebral cortex and hearing. Ann Otol Rhinol Laryngol. 1960;69:830–48.

    Article  CAS  PubMed  Google Scholar 

  9. Shiohama T, McDavid J, Levman J, Takahashi E. The left lateral occipital cortex exhibits decreased thickness in children with sensorineural hearing loss. Int J Dev Neurosci. 2019;76:34–40.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Burge WK, Griffis JC, Nenert R, Elkhetali A, DeCarlo DK, ver Hoef LW, et al. Cortical thickness in human V1 associated with central vision loss. Sci Rep. 2016;6:23268.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Hanson RLW, Gale RP, Gouws AD, Airody A, Scott MTW, Akthar F, et al. Following the status of visual cortex over time in patients with macular degeneration reveals atrophy of visually deprived brain regions. Invest Ophthalmol Vis Sci. 2019;60(15):5045–51.

    Article  PubMed  Google Scholar 

  12. Prins D, Plank T, Baseler HA, Gouws AD, Beer A, Morland AB, et al. Surface-based analyses of anatomical properties of the visual cortex in macular degeneration. PLoS One. 2016;11(1):e0146684.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Park HJ, Lee JD, Kim EY, Park B, Oh MK, Lee S, et al. Morphological alterations in the congenital blind based on the analysis of cortical thickness and surface area. Neuroimage. 2009;47(1):98–106.

    Article  PubMed  Google Scholar 

  14. Kran BS, Lawrence L, Mayer DL, Heidary G. Cerebral/cortical visual impairment: a need to reassess current definitions of visual impairment and blindness. Semin Pediatr Neurol. 2019;31:25–9.

    Article  PubMed  Google Scholar 

  15. Philip SS, Dutton GN. Identifying and characterising cerebral visual impairment in children: a review. Clin Exp Optom. 2014;97(3):196–208.

    Article  PubMed  Google Scholar 

  16. Haidar H, Soul JS. Measurement of cortical thickness in 3D brain MRI data: validation of the Laplacian method. J Neuroimaging. 2006;16(2):146–53.

    Article  PubMed  Google Scholar 

  17. Kang SH, Park YH, Lee D, Kim JP, Chin J, Ahn Y, et al. The cortical neuroanatomy related to specific neuropsychological deficits in Alzheimer’s continuum. Dement Neurocogn Disord. 2019;18(3):77–95.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Stephen R, Liu Y, Ngandu T, Antikainen R, Hulkkonen J, Koikkalainen J, et al. Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER). Alzheimers Res Ther. 2019;11(1):53.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Blanc F, Colloby SJ, Philippi N, de Petigny X, Jung B, Demuynck C, et al. Cortical thickness in dementia with Lewy bodies and Alzheimer’s disease: a comparison of prodromal and dementia stages. PLoS One. 2015;10(6):e0127396.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Im K, Lee JM, Seo SW, Yoon U, Kim ST, Kim YH, et al. Variations in cortical thickness with dementia severity in Alzheimer’s disease. Neurosci Lett. 2008;436(2):227–31.

    Article  CAS  PubMed  Google Scholar 

  21. Ye BS, Jeon S, Ham JH, Lee JJ, Lee JM, Lee HS, et al. Dementia-predicting cognitive risk score and its correlation with cortical thickness in Parkinson disease. Dement Geriatr Cogn Disord. 2017;44(3-4):203–12.

    Article  PubMed  Google Scholar 

  22. Jack CR Jr, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Mielke MM, et al. Age-specific population frequencies of cerebral beta-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study. Lancet Neurol. 2014;13(10):997–1005.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Park HY, Lim SY, Hwang JH, Choi JH, Koh WJ, Sung J, et al. Lung function, coronary artery calcification, and metabolic syndrome in 4905 Korean males. Respir Med. 2010;104(9):1326–35.

    Article  PubMed  Google Scholar 

  24. Kim CH, Seo SW, Kim GH, Shin JS, Cho H, Noh Y, et al. Cortical thinning in subcortical vascular dementia with negative 11C-PiB PET. J Alzheimers Dis. 2012;31(2):315–23.

    Article  CAS  PubMed  Google Scholar 

  25. Kim SE, Lee JS, Woo S, Kim S, Kim HJ, Park S, et al. Sex-specific relationship of cardiometabolic syndrome with lower cortical thickness. Neurology. 2019;93(11):e1045–e57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Collins DL, Neelin P, Peters TM, Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr. 1994;18(2):192–205.

    Article  CAS  PubMed  Google Scholar 

  27. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging. 1998;17(1):87–97.

    Article  CAS  PubMed  Google Scholar 

  28. Kim JS, Singh V, Lee JK, Lerch J, Ad-Dab’bagh Y, MacDonald D, et al. Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification. Neuroimage. 2005;27(1):210–21.

    Article  PubMed  Google Scholar 

  29. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002;17(3):143–55.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Lyttelton O, Boucher M, Robbins S, Evans A. An unbiased iterative group registration template for cortical surface analysis. Neuroimage. 2007;34(4):1535–44.

    Article  PubMed  Google Scholar 

  31. Im K, Lee JM, Lee J, Shin YW, Kim IY, Kwon JS, et al. Gender difference analysis of cortical thickness in healthy young adults with surface-based methods. Neuroimage. 2006;31(1):31–8.

    Article  PubMed  Google Scholar 

  32. Chan T, Friedman DS, Bradley C, Massof R. Estimates of incidence and prevalence of visual impairment, low vision, and blindness in the United States. JAMA Ophthalmol. 2018;136(1):12–9.

    Article  PubMed  Google Scholar 

  33. Zhu Z, Liao H, Wang W, Scheetz J, Zhang J, He M. Visual impairment and major eye diseases in chronic kidney disease: the National Health and Nutrition Examination Survey, 2005-2008. Am J Ophthalmol. 2020;213:24–33.

    Article  PubMed  Google Scholar 

  34. Wang J, Ying GS, Fu X, Zhang R, Meng J, Gu F, et al. Prevalence of myopia and vision impairment in school students in Eastern China. BMC Ophthalmol. 2020;20(1):2.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Malkin AG, Ross NC, Chan TL, Protosow K, Bittner AK. U.S. Optometrists’ reported practices and perceived barriers for low vision care for mild visual loss. Optom Vis Sci. 2020;97(1):45–51.

    Article  PubMed  Google Scholar 

  36. Li T, Xu X, Xu Y, Jin P, Chen J, Shi Y, et al. PPARG polymorphisms are associated with unexplained mild vision loss in patients with type 2 diabetes mellitus. J Ophthalmol. 2019;2019:5284867.

    PubMed  PubMed Central  Google Scholar 

  37. Lee JS, Shin HY, Kim HJ, Jang YK, Jung NY, Lee J, et al. Combined effects of physical exercise and education on age-related cortical thinning in cognitively normal individuals. Sci Rep. 2016;6:24284.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. de Haan EH, Cowey A. On the usefulness of ‘what’ and ‘where’ pathways in vision. Trends Cogn Sci. 2011;15(10):460–6.

    Article  PubMed  Google Scholar 

  39. Meyer SRA, De Jonghe JFM, Schmand B, Ponds R. Visual associations to retrieve episodic memory across healthy elderly, mild cognitive impairment, and patients with Alzheimer’s disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2019;26(3):447–62.

    Article  PubMed  Google Scholar 

  40. Mine M, Miyata K, Morikawa M, Nishi T, Okamoto N, Kawasaki R, et al. Association of visual acuity and cognitive impairment in older individuals: Fujiwara-kyo Eye Study. Biores Open Access. 2016;5(1):228–34.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Madan CR, Kensinger EA. Cortical complexity as a measure of age-related brain atrophy. Neuroimage. 2016;134:617–29.

    Article  PubMed  Google Scholar 

  42. Makino N, Maeda T, Oyama J, Higuchi Y. Role of the environmental factors on aging. Nihon Rinsho. 2009;67(7):1332–6.

    PubMed  Google Scholar 

  43. Manasatchakun P, Chotiga P, Hochwalder J, Roxberg A, Sandborgh M, Asp M. Factors associated with healthy aging among older persons in northeastern Thailand. J Cross Cult Gerontol. 2016;31(4):369–84.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Manolio TA. Study designs to enhance identification of genetic factors in healthy aging. Nutr Rev. 2007;65(12 Pt 2):S228–33.

    Article  PubMed  Google Scholar 

  45. McFall GP, McDermott KL, Dixon RA. Modifiable risk factors discriminate memory trajectories in non-demented aging: precision factors and targets for promoting healthier brain aging and preventing dementia. J Alzheimers Dis. 2019;70(s1):S101–S18.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Meyer JS, Akiyama H, Mortel KF, Konno S, Margishvili GM. Human aging: risk factors for cerebral atrophy. Ann N Y Acad Sci. 1997;826:483–9.

    Article  CAS  PubMed  Google Scholar 

  47. Nagano-Saito A, Bellec P, Hanganu A, Jobert S, Mejia-Constain B, Degroot C, et al. Why is aging a risk factor for cognitive impairment in Parkinson’s disease?-a resting state fMRI study. Front Neurol. 2019;10:267.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Ravaglia G, Forti P, Maioli F, Montesi F, Rietti E, Pisacane N, et al. Risk factors for dementia: data from the Conselice study of brain aging. Arch Gerontol Geriatr. 2007;44(Suppl 1):311–20.

    Article  PubMed  Google Scholar 

  49. Smith DB. Human factors and aging: an overview of research needs and application opportunities. Hum Factors. 1990;32(5):509–26.

    Article  CAS  PubMed  Google Scholar 

  50. Gauthier AC, Liu J. Neurodegeneration and neuroprotection in glaucoma. Yale J Biol Med. 2016;89(1):73–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Yamashita T, Miki A, Goto K, Araki S, Takizawa G, Ieki Y, et al. Retinal ganglion cell atrophy in homonymous hemianopia due to acquired occipital lesions observed using Cirrus high-definition-OCT. J Ophthalmol. 2016;2016:2394957.

    PubMed  PubMed Central  Google Scholar 

  52. Keller J, Sanchez-Dalmau BF, Villoslada P. Lesions in the posterior visual pathway promote trans-synaptic degeneration of retinal ganglion cells. PLoS One. 2014;9(5):e97444.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  53. Jindahra P, Petrie A, Plant GT. Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain. 2009;132(Pt 3):628–34.

    Article  PubMed  Google Scholar 

  54. Yucel YH, Zhang Q, Weinreb RN, Kaufman PL, Gupta N. Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res. 2003;22(4):465–81.

    Article  PubMed  Google Scholar 

  55. Rutland JW, Delman BN, Huang KH, et al. Primary visual cortical thickness in correlation with visual field defects in patients with pituitary macroadenomas: a structural 7-Tesla retinotopic analysis [published online ahead of print, 2019 Oct 18]. J Neurosurg. 2019:1-11. https://doi.org/10.3171/2019.7.JNS191712.

  56. Vottonen P, Paakkonen A, Tarkka IM, Kaarniranta K. Best-corrected visual acuity and retinal thickness are associated with improved cortical visual processing in treated wet AMD patients. Acta Ophthalmol. 2015;93(7):621–5.

    Article  CAS  PubMed  Google Scholar 

  57. Gupta N, Ang LC, Noel de Tilly L, Bidaisee L, Yucel YH. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol. 2006;90(6):674–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Li Q, Song M, Xu J, Qin W, Yu C, Jiang T. Cortical thickness development of human primary visual cortex related to the age of blindness onset. Brain Imaging Behav. 2017;11(4):1029–36.

    Article  PubMed  Google Scholar 

  59. Dinkin M. Trans-synaptic retrograde degeneration in the human visual system: slow, silent, and real. Curr Neurol Neurosci Rep. 2017;17(2):16.

    Article  PubMed  Google Scholar 

  60. Beatty RM, Sadun AA, Smith L, Vonsattel JP, Richardson EP Jr. Direct demonstration of transsynaptic degeneration in the human visual system: a comparison of retrograde and anterograde changes. J Neurol Neurosurg Psychiatry. 1982;45(2):143–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Mitchell JR, Oliveira C, Tsiouris AJ, Dinkin MJ. Corresponding ganglion cell atrophy in patients with postgeniculate homonymous visual field loss. J Neuroophthalmol. 2015;35(4):353–9.

    Article  PubMed  Google Scholar 

  62. Yu C, Liu Y, Li J, Zhou Y, Wang K, Tian L, et al. Altered functional connectivity of primary visual cortex in early blindness. Hum Brain Mapp. 2008;29(5):533–43.

    Article  PubMed  Google Scholar 

  63. Park SJ, Kwon KE, Choi NK, Park KH, Woo SJ. Prevalence and incidence of exudative age-related macular degeneration in South Korea: a nationwide population-based study. Ophthalmology. 2015;122(10):2063–70 e1.

    Article  PubMed  Google Scholar 

  64. Seo SJ, Lee YH, Lee SY, Bae HW, Hong S, Seong GJ, et al. Estimated prevalence of glaucoma in South Korea using the National Claims Database. J Ophthalmol. 2016;2016:1690256.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

G.H. and J.S.K. contributed equally as the first authors. H.J.K. and D.H.L. are the co-corresponding authors of this study.

Funding

This research was supported by the MSIT(Ministry of Science and ICT), Korea, under the ICT Creative Consilience program(IITP-2021-2020-0-01821) supervised by the IITP(Institute for Information & communications Technology Planning & Evaluation); a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (HU21C0111, HI19C1132, HI19C0481, and HC19C0142); and a grant from National Research Foundation of Korea grant funded by the Korean government’s Ministry of Education (NRF-2021R1C1C1007795; Seoul, Korea). The funding body had no roles in this study.

Author information

Author notes

  1. Gyule Han and Ji Sun Kim contributed equally as the first authors.

Authors and Affiliations

  1. Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea

    Gyule Han, Tae-Young Chung & Dong Hui Lim

  2. Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea

    Ji Sun Kim, Yu Hyun Park, Sung Hoon Kang, Hang-Rai Kim, Song Hwangbo, Duk L. Na, Sang Won Seo & Hee Jin Kim

  3. Alzheimer’s Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea

    Ji Sun Kim, Yu Hyun Park, Sung Hoon Kang, Hang-Rai Kim, Song Hwangbo, Duk L. Na, Sang Won Seo & Hee Jin Kim

  4. Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea

    Yu Hyun Park, Duk L. Na, Sang Won Seo & Hee Jin Kim

  5. Center for Health Promotion, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

    Hee Young Shin & Dong Hui Lim

  6. Department of Clinical Research Design & Evaluation, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea

    Sang Won Seo & Dong Hui Lim

  7. Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea

    Dong Hui Lim & Hee Jin Kim

Authors
  1. Gyule Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ji Sun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu Hyun Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sung Hoon Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hang-Rai Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Song Hwangbo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tae-Young Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hee Young Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Duk L. Na
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Sang Won Seo
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Dong Hui Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Hee Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

DHL and HJK: study design and conduct. GH, JSK, and YHP: data analysis. GH and JSK: writing of the manuscript. GH, JSK, and YHP: statistical analysis. JSK, SHK, H-RK, SH, and HYS: acquisition of the data. T-YC, DLN, and SWS: interpretation of the findings. DLN, SWS, DHL, and HJK: critical review of the manuscript. The authors read and approved the final manuscript.

Corresponding authors

Correspondence to Dong Hui Lim or Hee Jin Kim.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Institutional Review Board at Samsung Medical Center. All methods were conducted in accordance with the approved guidelines. The need for informed consent was waived by the Institutional Review Board at Samsung Medical Center, as we collected retrospective and de-identified data.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Fig. 1.

The distribution of visual acuity according to the age of the study participants. Grouped by VA in better-seeing eye: bad = VA ≤ 20/40, fair = 20/40 < VA ≤ 20/25, good = VA > 20/25 (VA was presented in Snellen system).

Additional file 2: Table S1.

Subgroup analysis of the relationship between cortical thickness (x 10-1mm) and visual acuity (VA) groups divided by VA types.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Han, G., Kim, J.S., Park, Y.H. et al. Decreased visual acuity is related to thinner cortex in cognitively normal adults: cross-sectional, single-center cohort study. Alz Res Therapy 14, 99 (2022). https://doi.org/10.1186/s13195-022-01045-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13195-022-01045-0

Keywords

Alzheimer's Research & Therapy

ISSN: 1758-9193